MedPath
TGA Approval

PFIZER DAUNORUBICIN daunorubicin (as hydrochloride) 18.7 mg powder for injection vial (399600)

399600

PFIZER DAUNORUBICIN daunorubicin (as hydrochloride) 18.7 mg powder for injection vial

Pfizer Australia Pty Ltd

September 1, 2023

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/ae7c3d09282948b410f2c7b0d45398fc.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/ed1b39b198f4063bf9b0965a8fad70c9.pdf

Active Ingredients

daunorubicin hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PFIZER DAUNORUBICIN daunorubicin (as hydrochloride) 18.7 mg powder for injection vial (399600) - TGA 批准文号 | MedPath